- GE Healthcare Life Sciences will supply Akeso Pharmaceuticals with the FlexFactory™ platform to accelerate the production of antibody drugs in the Guangzhou region
- Expected to be operational by end of 2020 and create up to 150 jobs upon opening.
November 6, 2019 – Uppsala, Sweden and Guangzhou, China – Akeso Pharmaceuticals, a biotech company specializing in the development and commercialization of novel biologics, will open a new facility in Guangzhou, China, based on GE Healthcare Life Sciences’ FlexFactory platform.